Sabaa International Company for Pharmaceutial and Chemical Industry (SIPC) Financials

Annual financial statement highlights for Sabaa International Company for Pharmaceutial and Chemical Industry covering fiscal years 2012–2024. Figures are updated weekly.

Fiscal yearRevenueNet incomeEPSFree cash flowTotal assetsTotal debtDividend per share
2024ended Dec 202422.73M-18.04M-0.07-2.08M168.76M340,0000.00
2023ended Dec 202313.25M1.16M0.002.32M170.35M80,000—
2022ended Dec 202218.07M20,0000.00-17.29M156.05M300,0000.00
2021ended Dec 2021 · 36 months44.07M6.78M0.023.44M155.99M4.04M0.00
2018ended Dec 201850.05M1.72M0.014.01M116.05M11.2M0.00
2017ended Dec 201784.04M17.41M0.071.68M115M8.77M0.00
2016ended Dec 201646.16M4.95M0.0210.84M88.23M1.49M0.00
2015ended Dec 201518.56M2.42M0.0140,00080.75M10.91M0.00
2014ended Dec 201415.24M2.4M0.012.82M70.56M5.28M0.00
2013ended Dec 201315.26M2.82M0.01—63.03M260,000—
2012ended Dec 201212.91M3.18M0.01—62.33M40,000—

All figures in EGP, as reported in the company’s annual results; updated weekly.